Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,225 public trials 3,228 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

S0820, Adenoma and Second Primary Prevention Trial

NCT01349881

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 990 locations
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NCT04963283

Conditions
Colon Adenocarcinoma, Colon Cancer, Colonic Diseases, +17 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
  • UCHealth Harmony Campus Fort Collins, Colorado, United States
  • UCHealth Family Medicine - Greeley Greeley, Colorado, United States
View Trial Details
Active, Not Recruiting

A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

NCT05984602

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Ambulatory Care Center New York, United States
  • Clinical Cancer Center New York, United States
  • NYU Langone Ambulatory Care Center East 38th Street New York, United States
View Trial Details
Active, Not Recruiting

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

NCT03408665

Conditions
Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +5 more
Locations
  • Centre Oscar Lambret Lille, Nord, France
  • Centre Léonard de Vinci Dechy, France
  • Institut Régional du Cancer de Montpellier Montpellier, France
  • Institut de Cancérologie Paris Nord Sarcelles, France
View Trial Details

Related conditions